Navigation Links
Grace Launches New REVELERIS® Prep Purification System
Date:7/30/2014

Columbia, MD (PRWEB) July 30, 2014

W. R. Grace & Co. (NYSE: GRA) announces today the release of the REVELERIS® Prep purification system, a dual-mode instrument that allows organic chemists, preparative chromatographers, and other researchers to perform both flash and preparative liquid chromatography (LC) using a single unit.

With the REVELERIS® Prep purification system, researchers can easily switch between flash and preparative chromatography modes with a simple touch of the screen, giving them complete control over the purification process and saving them time. The dual mode capability eliminates the need to change locations or departments when switching between flash and prep LC processes. The dual-mode instrument saves space in the laboratory and can reduce capital costs for equipment between 40 and 50 percent.

“The REVELERIS® Prep purification system allows researchers to maintain custody of samples throughout the entire purification process, eliminating the need for cumbersome and sometimes time-wasting handoffs between research teams or technicians," said Grace’s Adam Grose, Vice President and General Manager of the company’s Discovery Sciences unit.

The new system further enhances productivity by incorporating Grace’s REVEALX™ detection technology. This patented technology triggers fraction collection from multiple detector signals, yielding higher purity compounds in less time.

The REVELERIS® Prep purification system continues a revolution in flash chromatography that Grace started six years ago with the debut of the REVELERIS® flash chromatography system, the first flash system to integrate ELS detection and UV, enabling chemists to detect components and impurities previously undetectable with traditional UV systems. The REVELERIS® flash chromatography system has earned several major industry awards and four U.S. patents.

More information about the REVELERIS® Prep purification system is available at grace.com/RevelerisPrep.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12051595.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. National Press Club Celebration of the Publication of "The Grace of Stem Cells" by Jeong Chan Ra, Chairman of RNL BIO
2. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
3. Grace Century Attends Provia Laboratories Cycle II Launch
4. Dalia Dergham Joins Grace Century FZ LLC International Project Team
5. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
6. Grace Century Attends Provia Labs First Quarter Expansion Meeting January 5-10
7. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
10. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
11. Neogen Launches Fully Quantitative Lateral Flow Test for DON
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):